🔗 Share this article

An underground economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Acquiring Traction Online

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and chemists have cautions that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Several experts said the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Content Removal

Based on the social media company, the platform has taken down problematic content and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Online Marketplace Activities

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

After moments of joining one group, a seller posted WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.

Product Information and Pricing

Within these groups, messages show dark colored packages with postal service labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When questioned how much time a injector should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for Telegram said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her staff has previously encountered patients injured by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may expose users to possibly significant medical dangers”.